Xarelto Lawsuit Update: Number of Lawsuits Filed in MDL Rising

October 16, 2015 – – BloodThinnerHelp.com reports today on the updated number of lawsuits that are filed in the Xarelto MDL. Over the past few months the number of lawsuits that are filed in the federal multidistrict litigation, or MDL, has significantly increased. More than 400 additional lawsuits have been consolidated, bringing the total to 1,231 as of August 17, 2015. This is a huge increase for the Xarelto MDL because on July 15, 2015 only 805 lawsuits were consolidated. It is an even larger increase from the number filed in June which rested at about 500. For more detailed information on the status of the Xarelto lawsuits, click here.

Lawsuits Allege Xarelto is Dangerous:

These lawsuits are consolidated into the MDL because they all commonly allege that the anticoagulant Xarelto can cause serious, uncontrollable internal bleeding which leads to severe injury and even death. The lawsuits also allege that the manufacturers of the drug were aware of the dangers of the drug yet released it to market anyway and did not sufficiently warn patients and doctors about the risks associated with its usage.

Xarelto was first released onto the United States market in 2011 after it was approved by the Food and Drug Administration, FDA, to treat atrial fibrillation, deep vein thrombosis, and to be used in patients who have recently undergone a hip or knee replacement surgery. Xarelto is a part of a new class of blood thinners known as Xa inhibitors and the active drug in Xarelto is rivaroxaban. The manufacturers of Xarelto, drug conglomerates Bayer AG and Janssen Pharmaceuticals, marketed Xarelto as a safe and convienent alternative to the traditional blood thinner Warfarin. Unlike Warfarin, Xarelto does not require constant blood monitoring or a restrictive diet.

The lawsuits filed allege that Xarelto is not as safe as Warfarin because there is no antidote for the anticoagulant effects of Xarelto. This means that if a patient taking Xarelto suffers an internal bleeding event, it can become dangerous very quickly and turn into an uncontrollable bleed because there is no drug available to reverse the effects of Xarelto and make the blood clot.

Because of these dangers, Xarelto currently has two ‘black box’ warnings attached to it by the FDA. The black box warning is the strictest warning that the FDA can attach to a drug short of recalling it. It means that there is a reasonable risk of harm associated with the drug. For a full list of the FDA warnings regarding Xarelto, click here.

“If you believe that you or a loved one were harmed by Xarelto usage, contact us immediately.” Xarelto attorney Marc Goldich said, “If the manufacturers of the drug were aware of the dangers and put the drug to market anyway, they deserve to be brought to justice.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004739